Atricure is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.
Atricure is a publicly traded company on NGM using the ticker symbol ATRC.
Detailed information on company financials and operating reports can be found here:
NGM: ATRC
Note: Atricure's revenues are gauged from an analysis of company filings.
Trademark Applications
Trademark applications show the products and services that Atricure is developing and marketing.
Atricure doesn't have any recent trademark applications, indicating Atricure is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
QPATH Medical introducers, sheaths in the nature of surgical devices and instruments, and trocars
09/06/2019
ACT AGAINST AFIB Providing a website featuring non-downloadable educational videos and articles in the field of atrial fibrillation
07/24/2019
ENCOMPASS Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues
07/08/2019
See all trademarks and details in the Full Report.
Market Share of Atricure's Largest Competitors
A competitive analysis shows these companies are in the same general field as Atricure, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Atricure.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Atricure and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.